Author Jordan Boyd profileWhen the Centers for Disease Control and Prevention announced the U.S. birth rate reached a new low, there was much speculation about the culprit — and potential solutions. Instead of investigating those causes, however, Americans who just learned their replacement rate had officially lagged to 1.6 children per woman were bombarded with headlines promoting yet another “promising” new male contraceptive pill.

The hormone-free YCT-529 pill aims to hamper sperm production. The scientists running the first round of clinical trials concluded last week that the chemical “had no effects on heart rate, hormone (follicle-stimulating hormone, luteinizing hormone, and testosterone), sex hormone-binding globulin or inflammatory biomarker levels, sexual desire or mood.” ….

Continue reading >>>>>>>>>>>>>